SOLV · 8-K · 20260805PR000045
Guidance / Outlook
Solventum Corp · 2026-08-05 · Importance 62 · Surprise 68 · In source text
Solventum raised its full-year 2026 organic sales growth guidance to 2.5%–3.0%, compared with the prior range of 2.0%–3.0%. Excluding approximately 100 basis points of SKU-exit impact, the company expects organic sales growth of 3.5%–4.0%. It also increased adjusted EPS guidance to $7.10–$7.20 from the prior $6.40–$6.60 range and raised free cash flow guidance to $200 million–$300 million from approximately $200 million.
Key facts
- Full-year 2026 guidance: increased free cash flow range to $200 million to $300 million (from prior estimate of ~$200M) source
- Full-year 2026 guidance: increased adjusted EPS range to $7.10 to $7.20 (from prior upper end of $6.40 to $6.60) source
- Full-year 2026 guidance: increased organic sales growth range to +2.5% to +3.0% (+3.5% to +4.0% excluding ~100 bps of SKU exit impact) source
- Earnings conference call scheduled August 5, 2026 at 4:30 p.m. Eastern Time with conference ID 6342275 and dial-in numbers (800) 715-9871 U.S. and +1 (646) 307-1963 international source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +2.3% | Full-year 2026 guidance: increased organic sales growth range to +2.5% to +3.0% (+3.5% to +4.0% excluding ~100 bps of SKU exit impact) |
| cash | positive | committed | — | Full-year 2026 guidance: increased free cash flow range to $200 million to $300 million (from prior estimate of ~$200M) |
| net_income | positive | committed | — | Full-year 2026 guidance: increased adjusted EPS range to $7.10 to $7.20 (from prior upper end of $6.40 to $6.60) |